| J9271 | Injection, pembrolizumab, 1 mg | 13,310 | $40 | $572.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,210 | $60 | $76.4K |
| J0897 | Injection, denosumab, 1 mg | 2,580 | $20 | $46.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 370 | $100 | $35.8K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 150 | $120 | $18.2K |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community… | 110 | $130 | $14.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 130 | $100 | $12.5K |
| J9393 | Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mg | 1,000 | $10 | $12K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 200 | $60 | $11.7K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 60 | $130 | $7.9K |